Lung Cancer Clinical Trials in Cincinnati, OH

Lung Cancer Clinical Trials in Cincinnati, OH

View the best 10 lung cancer medical studies in Cincinnati, Ohio. Access promising new therapies by applying to a Cincinnati-based Lung Cancer clinical trial.

Trials in Cincinnati, Ohio

Here are the top 10 medical studies for lung cancer in Cincinnati, Ohio

Image of Local Institution in Irvine, United States.

Carboplatin +4 More

Alkylating agents

Recruiting1 awardPhase 2
This trial is testing a new treatment combining two immunotherapy drugs (relatlimab and nivolumab) with standard chemotherapy. It targets patients with advanced or recurrent lung cancer. The goal is to see if this combination improves outcomes compared to using just one immunotherapy drug with chemotherapy. Nivolumab has shown improved survival in the treatment of advanced non-small-cell lung cancer (NSCLC) previously treated with chemotherapy.
Image of University of California at Davis in Davis, United States.

ONC-392 +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial tests ONC-392, an antibody that helps the immune system fight cancer, in patients with advanced or spreading tumors who haven't responded to other treatments. It works by blocking a protein that usually keeps immune responses in check, making it easier for the body to attack cancer cells.
Image of ArriVent Investigative Site in Fairfax, United States.

Platinum-based Chemotherapy +1 More

Alkylating agents

Recruiting2 awardsPhase 3
This trial is testing furmonertinib at two different doses to treat a specific type of lung cancer. It targets patients with advanced or metastatic non-squamous NSCLC who have a particular genetic mutation. The medication works by blocking a protein that helps cancer cells grow, potentially slowing down or stopping the cancer.
Image of University of Florida Health Science Center - Jacksonville in Jacksonville, United States.

Proton Beam Radiation Therapy +1 More

Proton Beam Therapy

Recruiting3 awardsPhase 3
This trial is comparing two types of radiation therapy to see which is more effective in treating patients with stage II-IIIB non-small cell lung cancer- proton chemoradiotherapy versus photon chemoradiotherapy.
Image of Children's Hospital of Alabama in Birmingham, United States.

Thoracotomy +1 More

Procedure

Recruiting2 awardsPhase 3
This trial compares the effect of open thoracic surgery to thoracoscopic surgery in treating patients with osteosarcoma that has spread to the lung.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Docetaxel +3 More

Anti-metabolites

Recruiting1 awardPhase 2
This trial is studying giving maintenance chemotherapy with or without local consolidation therapy to see if it works better than maintenance chemotherapy alone in treating patients with stage IV non-small cell lung cancer.
Image of Mid Florida Hematology and Oncology Center ( Site 0018) in Orange City, United States.

Pembrolizumab

Recruiting2 awardsPhase 3
This trial aims to see if combining MK-2870 with pembrolizumab after surgery can effectively treat non-small cell lung cancer (NSCLC) in patients who did not have a complete
Image of Washington University School of Medicine - Siteman Cancer Center in Saint Louis, United States.

Quaratusugene Ozeplasmid

Virus Therapy

Recruiting1 awardPhase 1 & 2
This trial will test using a combination of quaratusugene ozeplasmid and atezolizumab as ongoing treatment for patients with Extensive Stage Small Cell Lung Cancer. The trial
Image of Providence - Saint Joseph Home Health in Anaheim, United States.

Phase 3 comparator arm +3 More

Chemotherapy

Recruiting1 awardPhase 2 & 3
This trial tests two drugs, MRTX849 and pembrolizumab, in patients with advanced lung cancer who have a specific genetic mutation. MRTX849 targets the mutation to stop cancer growth, while pembrolizumab boosts the immune system to fight the cancer. The study aims to see how well these treatments work alone and together.
Image of Sutter Auburn Faith Hospital in Auburn, United States.

Chemotherapy +2 More

Recruiting2 awardsPhase 3
This trial compares ramucirumab+pembrolizumab vs chemo for non-small cell lung cancer. Ramucirumab+pembrolizumab may stop tumors from growing and spreading, while chemo kills/stops cells from dividing/spreading. Results may help find out if this combo is more effective than chemo.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.